Eyeforpharma Barcelona 2020 is organized by eyeforpharma. The session will commence from Mar 31 – Apr 02, 2020, at International Barcelona Convention Center, Barcelona, Spain.
Description of Eyeforpharma:
Eyeforpharma Barcelona is an event that unites market access executives, key market access authorities and pharma leadership from across the commercial and clinical spectrum to hasten harmonization and spark our next evolutionary leap forward.
The biggest commercial pharma event
Being a pharmaceutical leader was once all about what you could sell. Marshalling your troops like a grand army, ready to fight for your share of voice. But customer expectations have moved on. We need a new kind of direction. One that is authentic, digitally native, all about data-driven decision-making, value-based on principle and empowering a new era of customer engagement.
To affect this change, 2000+ pharma leaders (from across Commercial, Marketing / Digital, Medical, Patient Engagement, Market Access, RWE and Clinical) will join healthcare’s brightest innovators at eyeforpharma Barcelona 2020 – where pharma decision-makers come to learn, collaborate and see the future of our industry.
Why Attend Eyeforpharma?:
• A cross-functional audience. Everyone in commercial pharma is there, all learning from each other.
• Ambitions to redefine pharma as the solution provider. Not just to run another conference.
• Over 80 solution providers. If you want to go shopping, this is the place to find the perfect partner.
• Curated content. Hundreds of discussions will go into preparing our agendas to ensure they’re tailored to your needs.
• Heavy Case-studies are performed as you need to see real, detailed examples. Our speakers will provide you with them.
Eyeforpharma 2020: 4 essential themes
• Authentic Leadership:
Assure integrity and accuracy in decision-making and portfolio design. Gain healthcare’s trust through medically-driven content, customer innovation, and holistic patient solutions
• Hit Commercial Goals:
Turn HCPs into influencers and encourage patient champions. Use content, education, empowerment, and open innovation to harness external relationships
• From Drugs to Treatments:
Use cloud platforms, data insights, and JVs with start-ups to generate a new suite of digital products, value-added services, and cell & gene therapies. Go from druggable & reactive to curable & preventative
• Digitize Evidence:
Prepare a superior mix of virtual clinical trials and regulatory-grade RWE to gain authorization, widen access, boost launch and drive patient outcomes